To view this email as a web page, click here.
 
RA drug could help pharma maker stunt Humira losses
Blockbuster drug could be key to Humira’s successor.
Read more
 
New drug targets key genetic driver of cancer
FDA approved the third oncology drug in the US that targets a key genetic driver of cancer, rather than a specific tumor.
Read more
 
Four ways precision medicine impacts cancer treatment
From our sister brand Drug Topics: Here are the top 4 ways precision medicine is expected to impact cancer treatment.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.